The startup will represent about 4% of the Ark Venture Fund's holdings.
With stocks and bonds moving increasingly in tandem, investors have been forced elsewhere for protection.
The firm is skimming some profits as Magnificent 7 stock returns start to diverge.
Vertiv Holdings has delivered a 553% return.
Pet ownership has risen steadily since the mid-1990s, with the Covid-19 pandemic spurring more adoptions.
JPMorgan's CEO says AI could “augment virtually every job.”
AI investors are pointing toward emerging markets for better value and a bigger pool of options.
Amazon had more than $86 billion in cash at the end of 2023.
There is little reason to believe that the current rally can last.
The Janus Henderson Global Life Sciences Fund successfully navigates the turbulent healthcare sector.
Euro area shares have risen by around 4% in March, outpacing their US peers.
Researchers are questioning how long the current five-month rally in equities can last.
The S&P 500 is already trading 3% above Citigroup's end-year target of 5,100.
Twenty years ago, advisor Harold Evensky interviewed the late Daniel Kahneman about how to apply behavioral finance to client management.
Portfolio allocations indicate advisors expect a good environment for growth stocks, the company's analysts said.
Psychedelics have long struggled to gain regulatory acceptance.
The semiconductor industry is notoriously cyclical, with regular boom and bust cycles.
Economist Ed Yardeni thinks Fed Chairman Jerome Powell might be changing his tough-guy tune.
Regionally, dealmakers in the US have led the charge in the opening months of 2024.
A total of 46 listed biotech deals worth more than $100 billion were announced last year.